FDA New Drug and Biologic Approvals -- 2017 Year-in-Review

Mary L Windle, PharmD


January 11, 2018

In This Article

New Infectious Disease Dosage Forms

Shingrix (zoster vaccine recombinant)

New adjuvanted herpes zoster (shingles) vaccine approved in adults aged 50 years or older. Provides a strong and long-lasting immune response to help overcome the decline in immunity as people age.

Heplisav-B (hepatitis B vaccine)

New 2-dose series that is administered at 0 and 1 month.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.